Stress-induced hematopoietic failure in the absence of immediate early response gene X-1 (IEX-1, IER3)
Name
Ramsey-2014-Stress-induced hemat.pdf
Size
1.13 MB
Format
Adobe PDF
Checksum (MD5)
788f03d2933401298f22a0519df54f18
Author(s) • • • • •
Ramsey, Haley
Zhang, Qi
Brown, Diane E.
Steensma, David P.
Lin, Charles
Wu, Mei X.
Date Issued
September 2013
Journal
Haematologica
Publisher
Ferrata Storti Foundation
Citation
Ramsey, H., Q. Zhang, D. E. Brown, D. P. Steensma, C. P. Lin, and M. X. Wu. “Stress-Induced Hematopoietic Failure in the Absence of Immediate Early Response Gene X-1 (IEX-1, IER3).” Haematologica 99, no. 2 (February 1, 2014): 282–291. © Ferrata Storti Foundation
Version
Final published version
Abstract
Expression of the immediate early response gene X-1 (IEX-1, IER3) is diminished significantly in hematopoietic stem cells in a subgroup of patients with early stage myelodysplastic syndromes, but it is not clear whether the deregulation contributes to the disease. The current study demonstrates increased apoptosis and a concomitant decrease in the number of hematopoietic stem cells lacking this early response gene. Null mutation of the gene also impeded platelet differentiation and shortened a lifespan of red blood cells. When bone marrow cells deficient in the gene were transplanted into wild-type mice, the deficient stem cells produced significantly fewer circulating platelets and red blood cells, despite their enhanced repopulation capability. Moreover, after exposure to a non-myeloablative dose of radiation, absence of the gene predisposed to thrombocytopenia, a significant decline in red blood cells, and dysplastic bone marrow morphology, typical characteristics of myelodysplastic syndromes. These findings highlight a previously unappreciated role for this early response gene in multiple differentiation steps within hematopoiesis, including thrombopoiesis, erythropoiesis and in the regulation of hematopoietic stem cell quiescence. The deficient mice offer a novel model for studying the initiation and progression of myelodysplastic syndromes as well as strategies to prevent this disorder.
MIT Department
Harvard University--MIT Division of Health Sciences and Technology
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.3324/haematol.2013.092452